摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4-氯-苯基)-(2,4-二甲氧基-苯乙烯基)-酮 | 18493-31-7

中文名称
(4-氯-苯基)-(2,4-二甲氧基-苯乙烯基)-酮
中文别名
——
英文名称
1-(2,4-Dimethoxy-phenyl)-3-(4-chlor-phenyl)-propenon-(3)
英文别名
3-(4-Chlor-phenyl)-1-(2,4-dimethoxy-phenyl)-propen-(1)-on-(3);p-Chlorphenyl-β-(2,4-dimethoxyphenyl)-vinyl-keton;(4-Chlor-phenyl)-(2,4-dimethoxy-styryl)-keton;1-(4-chlorophenyl)-3-(2,4-dimethoxyphenyl)prop-2-en-1-one
(4-氯-苯基)-(2,4-二甲氧基-苯乙烯基)-酮化学式
CAS
18493-31-7
化学式
C17H15ClO3
mdl
——
分子量
302.757
InChiKey
RIAYIRFYWCEXLV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    123 °C
  • 沸点:
    470.8±45.0 °C(Predicted)
  • 密度:
    1.212±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    21
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

SDS

SDS:dc148206897769d501a51cc755406a4c
查看

反应信息

  • 作为反应物:
    描述:
    (4-氯-苯基)-(2,4-二甲氧基-苯乙烯基)-酮 在 potassium hydroxide 作用下, 以 乙醇 为溶剂, 反应 1.5h, 生成 (Z)-3-(4-(4-chlorophenyl)-6-(2,4-dimethoxyphenyl)pyrimidin-2-ylimino)indolin-2-one
    参考文献:
    名称:
    新型吲哚-2-酮偶合嘧啶衍生物的超声介导合成,生物评价,对接和体内急性口服毒性研究
    摘要:
    这项工作报告了11种新型3-(4-(4-氯苯基)-6-(取代的苯基/杂芳基嘧啶-2-ylimino)吲哚满-2-一(7a – 7k)衍生物的超声介导的绿色合成。评估合成的衍生物对一组选定的人类乳腺癌细胞系乳腺癌(MCF-7),宫颈(HeLa),前列腺(PC-3)和肺(A-549)的体外抗癌活性。在测试的化合物中,7b对HeLa,PC-3和A-549表现出最有希望的体外抗癌活性,GI 50分别为15.38、19.67和4.37 µM。还筛选了化合物(7a – 7k)在其GI 50时诱导癌细胞凋亡和形态变化。浓度。用7b处理HeLa,PC-3和A549癌细胞以及用7h处理MCF-7癌细胞显示出凋亡和形态学变化,例如细胞收缩,细胞壁变形和存活细胞数量减少。与RWPE-1正常前列腺上皮细胞相比,化合物7b对PC-3癌细胞系的选择性提高了近5.00倍。已经进行了分子对接研究,该研究复制了初次命中7b
    DOI:
    10.1007/s11164-018-3292-5
  • 作为产物:
    描述:
    对氯苯乙酮2,4-二甲氧基苯甲醛 在 potassium hydroxide 作用下, 以 乙醇 为溶剂, 反应 0.33h, 以84%的产率得到(4-氯-苯基)-(2,4-二甲氧基-苯乙烯基)-酮
    参考文献:
    名称:
    新型吲哚-2-酮偶合嘧啶衍生物的超声介导合成,生物评价,对接和体内急性口服毒性研究
    摘要:
    这项工作报告了11种新型3-(4-(4-氯苯基)-6-(取代的苯基/杂芳基嘧啶-2-ylimino)吲哚满-2-一(7a – 7k)衍生物的超声介导的绿色合成。评估合成的衍生物对一组选定的人类乳腺癌细胞系乳腺癌(MCF-7),宫颈(HeLa),前列腺(PC-3)和肺(A-549)的体外抗癌活性。在测试的化合物中,7b对HeLa,PC-3和A-549表现出最有希望的体外抗癌活性,GI 50分别为15.38、19.67和4.37 µM。还筛选了化合物(7a – 7k)在其GI 50时诱导癌细胞凋亡和形态变化。浓度。用7b处理HeLa,PC-3和A549癌细胞以及用7h处理MCF-7癌细胞显示出凋亡和形态学变化,例如细胞收缩,细胞壁变形和存活细胞数量减少。与RWPE-1正常前列腺上皮细胞相比,化合物7b对PC-3癌细胞系的选择性提高了近5.00倍。已经进行了分子对接研究,该研究复制了初次命中7b
    DOI:
    10.1007/s11164-018-3292-5
点击查看最新优质反应信息

文献信息

  • Reinvestigation of structure–activity relationship of methoxylated chalcones as antimalarials: Synthesis and evaluation of 2,4,5-trimethoxy substituted patterns as lead candidates derived from abundantly available natural β-asarone
    作者:Rakesh Kumar、Dinesh Mohanakrishnan、Abhishek Sharma、Naveen Kumar Kaushik、Kalpana Kalia、Arun Kumar Sinha、Dinkar Sahal
    DOI:10.1016/j.ejmech.2010.08.049
    日期:2010.11
    causes a decrease. In particular, 2,4,5-trimethoxy substitution pattern at ring A provided potent analogues which were easily derived from abundantly available natural β-asarone rich Acorus calamus oil. Cytotoxic evaluation indicated that the most active compounds 27 (IC50: 1.8 μM) and 26 (IC50: 2 μM) were also relatively non-toxic. Furthermore, compound 12 showed excellent resistance index of 1.1 against
    我们已经使用基于荧光的SYBR Green分析方法检测了一系列甲氧基化查耳酮(A –CH CH–CO– B)对恶性疟原虫(3D7株)的抗疟结构与活性的关系。我们的研究表明,环A上的释放电子的甲氧基和环B上的吸电子基团提高了抗疟药的效力,而这些基团的位置互换导致其降低。特别地,在环2,4,5-三甲氧基取代模式甲提供一种很容易从可大量获得的天然衍生的强效的类似物β细辛醚丰富菖蒲油。细胞毒性评估表明,活性最高的化合物27(IC 50:1.8μM)和26(IC 50:2μM)也是相对无毒的。此外,化合物12对P的耐氯喹Dd2菌株显示出优异的抗性指数1.1 。恶性肿瘤。
  • Synthesis and cytotoxic activities of some pyrazoline derivatives bearing phenyl pyridazine core as new apoptosis inducers
    作者:Riham F. George、Marwa A. Fouad、Iman E.O. Gomaa
    DOI:10.1016/j.ejmech.2016.01.048
    日期:2016.4
    to the formation of new pyrazoline derivatives 8a-8u. All final compounds were characterized by spectral and elemental analyses. They were screened for their antiproliferative activities against A549 (lung), HepG-2 (liver), CaCo-2 (intestinal) and MCF-7 (breast) cancer cell lines. Some of the synthesized compounds exhibited promising antiproliferative activities especially compound 8k with IC50 values
    在碱性条件下,将查尔酮3a - 3u与3-肼基-6-苯基哒嗪7环合导致形成新的吡唑啉衍生物8a-8u。所有最终化合物均通过光谱和元素分析进行​​表征。筛选了它们对A549(肺),HepG-2(肝),CaCo-2(肠)和MCF-7(乳腺癌)癌细胞系的抗增殖活性。某些合成的化合物显示出有希望的抗增殖活性,尤其是具有IC 50的化合物8k分别针对HepG-2,MCF-7和CaCo-2癌细胞系的8.33、1.67和10μM的最高值。此外,它们的抗增殖活性是由于细胞凋亡而不是坏死诱导,除了化合物8h表现出相同的凋亡和坏死特性。化合物8k显示caspase-3活性增加了5倍,表明细胞凋亡通过caspase-3活化而进行。
  • Synthesis and bioactivities of pyrazoline benzensulfonamides as carbonic anhydrase and acetylcholinesterase inhibitors with low cytotoxicity
    作者:Dilan Ozmen Ozgun、Halise Inci Gul、Cem Yamali、Hiroshi Sakagami、Ilhami Gulcin、Murat Sukuroglu、Claudiu T. Supuran
    DOI:10.1016/j.bioorg.2018.12.028
    日期:2019.3
    and 200 µM towards OSCC malign cell lines. Their tumor selectivities were also calculated with two ways. Compound's selectivities towards cancer cell line were found generally low, except compounds bearing 3,4-dimethoxyphenyl 14 (TS1 = 1.3, TS2 = 1.4) and 10 (TS2 = 1.4). All sulfonamide derivatives studied here can be considered as good candidates to develop novel CAs or AChE inhibitor candidates based
    合成了4-(3-取代的苯基-5-聚甲氧基苯基-4,5-二氢-1H-吡唑-1-基)苯磺酰胺(9-16),并通过1H NMR,13C NMR和HRMS阐明了它们的化学结构。通过hibrit分子方法,所设计的化合物在单个分子中包括吡唑啉和磺酰胺药效团,这是药物化学中有用的技术,可用于设计对所需的几种生物活性具有有效活性的新化合物。评估了磺酰胺类对人CA同工酶(hCA IandhCA II)和乙酰胆碱酯酶(AChE)酶的抑制能力,并研究了它们对口腔鳞癌(OSCC)细胞系(Ca9-22,HSC-2,HSC- 3,以及HSC-4)和非肿瘤细胞(HGF,HPLF和HPC)。磺酰胺衍生物可抑制胞质hCA I和hCA II同工酶(9-16),Ki值分别在27.9±3.2-74.3±28.9 nM和27.4±1.4-54.5±11.6 nM之间。AChE酶被磺酰胺衍生物强烈抑制,Ki值在37.7±14.4-89
  • Efficient and Eco-friendly Syntheses of 1,5-Benzothiazepines and 1,5-Benzodiazepines Catalyzed by [<i>Hmim</i>][NO<sub>3</sub>] under Mild Conditions
    作者:Hossein Loghmani-Khouzani、Panteha Tamjidi、Iraj Mohammadpoor-Baltork、Marzieh Yaeghoobi、Noorsaadah Abd. Rahman、Ahmad Reza Khosropour、Majid Moghadam、Shahram Tangestaninejad、Valiolah Mirkhani、Mohammad Hossein Habibi、Ayana Kashima、Takayoshi Suzuki
    DOI:10.1002/jhet.1827
    日期:2014.1
    Crystal structures of a new thiazepine and diazepine (seven‐membered rings) have also been determined and compared with thiazine (six‐membered ring). In this method, N‐methylimidazolium nitrate [Hmim][NO3] has been used as a catalyst that acts as an environmental friendly system.
    本文介绍了1,5-苯并噻氮杂类和1,5-苯并二氮杂类衍生物的合成方法和反应机理。在这项研究中,已经用新方法制备了36种噻嗪类和二氮杂品(大多数是新的),并通过分光镜方法对其结构进行了表征。还确定了新的噻氮平和二氮杂(七元环)的晶体结构,并将其与噻嗪(六元环)进行了比较。在此方法中,硝酸N甲基咪唑鎓盐[ Hmim ] [NO 3 ]被用作催化剂,对环境无害。
  • Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents
    作者:Babasaheb P. Bandgar、Shrikant S. Gawande、Ragini G. Bodade、Jalinder V. Totre、Chandrahas N. Khobragade
    DOI:10.1016/j.bmc.2009.11.066
    日期:2010.2
    Chalcones have been identified as interesting compounds with cytotoxicity, anti-inflammatory and antioxidant properties. In the present study, simple methoxychalcones were synthesized by Claisen-Schmidt condensation reaction and evaluated for above biological activities. The structures of the compounds were established by IR, (1)H NMR and mass spectral analysis. The data revealed that compound 3s (99-100% at 10 mu M concentration) completely inhibit the selected five human cancer cell lines as compared to standard flavopiridol and gemcitabine (70-90% at 700 nM and 500 nM concentrations, respectively), followed by 3a, 3n, 3o, 3p, 3q, 3r. Among the tested compounds 3l, 3m, 3r, and 3s exhibited promising anti-inflammatory activity against TNF-alpha and IL-6 with 90-100% inhibition at 10 mu M concentration. DPPH free radical scavenging activity was given by the compounds 3o, 3n, 3l, 3r, 3m, 3a, 3p, 3c and 3s at 1 mM concentration. Overall, 3s was obtained as lead compound with promising anticancer, anti-inflammatory and antioxidant activities. Bioavailability of compounds were checked by in vitro cytotoxicity study and confirmed to be nontoxic. The structure activity relationship (SAR) and in silico drug relevant properties (HBDs, HBAs, PSA, c Log P, ionization potential, molecular weight, E(HOMO) and E(LUMO)) further confirmed that the compounds were potential candidates for future drug discovery study. (C) 2009 Elsevier Ltd. All rights reserved.
查看更多